Politicians / $HAE

Ticker research · released through 2026-09-20

Which members of Congress bought Haemonetics ($HAE)?

As of 2026-09-27, 4 members of Congress disclosed buying Haemonetics (HAE) in CopyGov's publicly released record. The most recent published buy was attributed to Josh Gottheimer on 2020-11-05; its modeled entry was 2020-11-06. Copying at the first close after publication returned +6.8% to 2026-09-25, or -131.6 points versus SPY.

Source checked 2026-09-27 · Latest completed matched close 2026-09-25 · Disclosure and transaction dates differ.

Members with disclosed buys

Disclosure-by-disclosure copy returns

MemberPublishedModeled entryCopy return to 2026-09-25SPY same datesOriginal PTR
Josh Gottheimer2020-11-052020-11-06+6.8% · $68 per $1,000+138.4% · -131.6 pts excessOfficial source ↗
Rohit Khanna2020-10-212020-10-22-1.4% · $-14 per $1,000+142.2% · -143.6 pts excessOfficial source ↗
Lois Frankel2020-08-242020-08-25+17.5% · $175 per $1,000+143.5% · -126.0 pts excessOfficial source ↗
Gilbert Cisneros2020-06-162020-06-17+19.4% · $194 per $1,000+170.1% · -150.7 pts excessOfficial source ↗
Josh Gottheimer2020-06-102020-06-11+17.8% · $178 per $1,000+180.0% · -162.2 pts excessOfficial source ↗

Common questions

Who in Congress bought HAE?

Josh Gottheimer, Rohit Khanna, Lois Frankel, Gilbert Cisneros have publicly released HAE purchase signals in CopyGov through 2026-09-20. Each row below links to its original filing.

When did Pelosi buy HAE?

No Pelosi-household HAE purchase is currently in CopyGov's released record through 2026-09-20.

What would copying have returned?

For the latest released HAE buy, copying at the first close after publication returned +6.8% to 2026-09-25, compared with +138.4% for SPY over the same dates. The excess was -131.6 percentage points after 10 basis points per side.

The model enters at the first completed close after publication, not the original trade price, assumes 10 basis points per side, and ignores later sales. Verify ownership and amounts in the original PTR. Past outcomes are not forecasts.

Get Congress trade alerts →